Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.535
Peer-review started: November 7, 2019
First decision: December 7, 2019
Revised: January 6, 2020
Accepted: January 11, 2020
Article in press: January 11, 2020
Published online: February 7, 2020
There are few effective tools to predict survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas.
To develop comprehensive nomograms to individually estimate the survival outcome of patients with invasive intraductal papillary mucinous neoplasms of the pancreas.
Data of 1219 patients with invasive intraductal papillary mucinous neoplasms after resection were extracted from the Surveillance, Epidemiology, and End Results database, and randomly divided into the training (n = 853) and the validation (n = 366) cohorts. Based on the Cox regression model, nomograms were constructed to predict overall survival and cancer-specific survival for an individual patient. The performance of the nomograms was measured according to discrimination, calibration, and clinical utility. Moreover, we compared the predictive accuracy of the nomograms with that of the traditional staging system.
In the training cohort, age, marital status, histological type, T stage, N stage, M stage, and chemotherapy were selected to construct nomograms. Compared with the American Joint Committee on Cancer 7th staging system, the nomograms were generally more discriminative. The nomograms passed the calibration steps by showing high consistency between actual probability and nomogram prediction. Categorial net classification improvements and integrated discrimination improvements suggested that the predictive accuracy of the nomograms exceeded that of the American Joint Committee on Cancer staging system. With respect to decision curve analyses, the nomograms exhibited more preferable net benefit gains than the staging system across a wide range of threshold probabilities.
The nomograms show improved predictive accuracy, discrimination capability, and clinical utility, which can be used as reliable tools for risk classification and treatment recommendations.
Core tip: Due to its rarity, it is difficult to develop a prognostic nomogram for intraductal papillary mucinous neoplasms (IPMNs) of the pancreas in a single institution; however, the Surveillance, Epidemiology, and End Results database has provided useful data on prognosis. To date, no study has focused on a predictive model for the prognosis of IPMNs. In this study, we developed nomograms to predict the probability of overall survival and cancer-specific survival at different time points in patients with invasive IPMNs of the pancreas based on the Surveillance, Epidemiology, and End Results dataset. Compared with the American Joint Committee on Cancer 7th staging system, the formulated nomograms in this study showed perfect performance in terms of discrimination, calibration, reclassification, and clinical usefulness.